Log in to save to my catalogue

Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigil...

Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigil...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_405474d19bc14e7bbe003f7abb5de791

Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study

About this item

Full title

Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2024-12, Vol.14 (1), p.223-10, Article 223

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Multiple myeloma (MM) is a complex hematological malignancy of clonal plasma cells driven by alterations to the chromosomal material leading to uncontrolled proliferation in the bone marrow. Ethnic and racial disparities persist in the prevalence, diagnosis, management, and outcomes of MM. These disparities are multifaceted and intersect with vario...

Alternative Titles

Full title

Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_405474d19bc14e7bbe003f7abb5de791

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_405474d19bc14e7bbe003f7abb5de791

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-024-01206-4

How to access this item